Guide

Pharmaceutical GMP readiness in Switzerland

Switzerland regulates medicines through Swissmedic under the Therapeutic Products Act (TPA / HMG SR 812.21) and the Medicinal Products Licensing Ordinance (AMBV/OAMéd). Swiss GMP follows PIC/S; the EU–Switzerland Mutual Recognition Agreement (MRA) means EU and Swiss GMP inspections recognize each other for human medicines. Batch release uses a Swiss Qualified Person (Fachtechnisch verantwortliche Person, FvP). This guide covers the Switzerland-specific layer over an ICH Q10 PQS.

Start free trial Free trial, no credit card, onboard in days, not months.

Regulator and legal basis

Swissmedic is the federal authority for therapeutic products. TPA is the statutory base; AMBV/OAMéd governs manufacturing, import, wholesale, and brokering licences (BTM, GDP). Swissmedic is a PIC/S member and references EudraLex Volume 4 plus Swiss annexes. Cantonal authorities cooperate on wholesale and pharmacy oversight.

FvP / Qualified Person and licence model

Every manufacturing and import authorisation requires a named FvP (the Swiss QP) accountable for GMP and batch release. The FvP function is statutory and personally liable. A single FvP can cover one or more sites with adequate presence and competence.

EU MRA, GDP, and serialization

Under the EU–CH MRA for human medicines, GMP certificates and inspection outcomes are mutually recognized — EU batch testing waivers apply, and Swissmedic inspections cover EU MRA partners' needs and vice versa. Swiss GDP mirrors EU GDP. Switzerland is NOT in the EU FMD scheme — packs for the Swiss market do not require EMVS verification, but most manufacturers retain the 2D Datamatrix for global packs.

Inspection style and common findings

Swissmedic inspections are PIC/S-style with critical/major/other classifications and a published certificate. Common findings: Annex 1 contamination control, computerised systems / Annex 11, data integrity (ALCOA+), and supplier oversight. Swissmedic is small but technically demanding; expect detailed scientific debate at inspection.

A 90–180 day Switzerland readiness path

Days 0–30: confirm BTM/GDP licence scope, appoint FvP(s), and document the EU MRA reliance position for imported batches. Days 31–90: close Annex 1 and Annex 11 gaps; align data integrity to MHRA/PIC/S PI 041. Days 91–180: mock inspection against EudraLex Vol 4 + Swiss annexes; request Swissmedic inspection.

Standards covered in this guide

Each standard, retailer code or assurance scheme referenced above has its own deep-dive page with scope, audit detail and common pitfalls.

Swissmedic

Swissmedic — the Swiss Agency for Therapeutic Products (Schweizerisches Heilmittelinstitut / Institut suisse des produits thérapeutiques) — Switzerland's national competent authority for medicines + medical devices.

QP release

EU GMP — only a named Qualified Person can certify a batch for market release.

EU GDP

Binding EU/EEA standard for wholesale distribution of medicinal products — quality system, Responsible Person, qualified premises and transport, supplier and customer verification, FMD safeguards, returns, recalls, transportation.

EU GMP Annex 1 Sterile

EU GMP Annex 1 (revision effective 25 August 2023, with full lyophilisation-section compliance from 25 August 2024) is the world's most influential sterile-manufacturing standard — adopted by EU, MHRA

EU Annex 11

European equivalent of 21 CFR Part 11 — rules for computerised systems in GMP.

ALCOA+

The nine-letter mnemonic regulators use to grade your data integrity — and what every Part 11 audit really tests.

Where this lives in V5 Ultimate

The clauses above aren't theoretical — every one maps to a shipped module and an industry profile. Jump to the parts of the product that turn this guide into evidence on a Monday morning.

Industries this hits hardest

Frequently asked

Does the EU–CH MRA cover all medicines?

It covers human medicinal products (chemicals and biologicals); coverage of veterinary medicines, IMPs, and some advanced therapies is narrower. Always check the current MRA annex before relying on it for a specific product class.

Is FvP the same as an EU QP?

Functionally equivalent — the FvP carries personal accountability for GMP compliance and batch release. Eligibility is set by Swiss law and is generally accepted by EU QPs under the MRA, though formal cross-recognition of the role itself is not automatic.

Do we need FMD serialization for Swiss packs?

Not legally. Switzerland is outside the EU FMD/EMVS system. Many manufacturers keep the 2D Datamatrix carrier for traceability and to share packs with EU markets via parallel trade rules, but Swissmedic does not enforce FMD.

See it on your shop floor.

Free trial, no credit card, onboard in days, not months.

Start free trial See pricing →Browse all resources →